Eisai
4523.T
#2011
Rank
ยฃ6.20 B
Marketcap
ยฃ22.00
Share price
-0.53%
Change (1 day)
-42.32%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): ยฃ1.80

According to Eisai's latest financial reports the company's current EPS (TTM) is ยฃ1.74. In 2022 the company made an earnings per share (EPS) of ยฃ1.28 a decrease over its 2021 EPS that were of ยฃ5.66.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ1.8041.44%
2022ยฃ1.28-77.48%
2021ยฃ5.66-41.88%
2020ยฃ9.74-0.94%
2019ยฃ9.8352.59%
2018ยฃ6.44124.17%
2017ยฃ2.87-49.42%
2016ยฃ5.6837.08%
2015ยฃ4.15-11.75%
2014ยฃ4.70-3.23%
2013ยฃ4.85-18.56%
2012ยฃ5.96-15.51%
2011ยฃ7.06-3.75%
2010ยฃ7.33-1.36%
2009ยฃ7.43